Horizon Therapeutics Plc - Company Profile
Powered by 
All the data and insights you need on Horizon Therapeutics Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Horizon Therapeutics Plc Strategy Report
- Understand Horizon Therapeutics Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Horizon Therapeutics Plc Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Horizon Therapeutics Plc’s relevant decision makers and contact details.
A sample of Horizon Therapeutics Plc Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 12 Dec 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 12 Dec 2022 | Mergers & Acquisitions | Amgen to Acquire Horizon Therapeutics | Horizon Therapeutics Plc | (famotidine + naproxen IR); (sodium benzoate + sodium phenylacetate); ADX-914; Alpine; cysteamine DR; daxdilimab; dazodalibep; DiaPep-277; diclofenac sodium; ethinyl estradiol; fipaxalparant; fomepizole; glycerol phenylbutyrate; Gout Target 2; HemoShear; HepTide; HZN-002; HZN-003; HZN-1116; HZN-457; inebilizumab; interferon gamma-1b; interferon gamma-1b next generation; levofloxacin; mAb cytokine fusion protein; NeuroTrans Program; NGX-426; NGX-555; prednisone DR; RP-104; RP-105; RP-106; Small Molecules for Metabolic Disorders and Oncology; Small Molecules to Inhibit Cysteamine Dioxygenase for Cystinosis; sodium phenylbutyrate; tarenflurbil; teprotumumab; VIB-9600; WntTide; XL-400 | Cardiovascular; Central Nervous System; Dermatology; Gastrointestinal; Genetic Disorders; Genito Urinary System And Sex Hormones; Hematological Disorders; Hormonal Disorders; Immunology; Infectious Disease; Metabolic Disorders; Musculoskeletal Disorders; Oncology; Ophthalmology; Respiratory; Toxicology; Undisclosed |
| 29 Nov 2022 | Mergers & Acquisitions | Amgen, Janssen Global Services and Sanofi May Acquire Horizon Therapeutics | Amgen Inc | - | Cardiovascular; Central Nervous System; Dermatology; Gastrointestinal; Genito Urinary System And Sex Hormones; Hematological Disorders; Hormonal Disorders; Immunology; Infectious Disease; Metabolic Disorders; Musculoskeletal Disorders; Oncology; Ophthalmology; Respiratory |
| 29 Nov 2022 | Mergers & Acquisitions | Amgen, Janssen Global Services and Sanofi May Acquire Horizon Therapeutics | Sanofi | - | Cardiovascular; Central Nervous System; Dermatology; Gastrointestinal; Genito Urinary System And Sex Hormones; Hematological Disorders; Hormonal Disorders; Immunology; Infectious Disease; Metabolic Disorders; Musculoskeletal Disorders; Oncology; Ophthalmology; Respiratory |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward